BBNX — Beta Bionics, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1674632 ·
Last close
$14.72
Market Cap
$800.28M
52W High
$32.71
52W Low
$8.80
ADV30
1,120,258
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 35,505,000 | 20,331,000 | -26,609,000 | -24,353,000 | 443,759,000 | 81,551,000 | 42,376,000 |
| Jun 2026 | 32,013,000 | 18,902,000 | -25,578,000 | -23,403,000 | 292,387,000 | 44,318,000 | 36,021,000 |
| Mar 2026 | 27,626,000 | 16,437,000 | -24,271,000 | -21,895,000 | 304,417,000 | 30,206,000 | 33,172,000 |
| Dec 2025 | 32,121,000 | 18,944,000 | -16,124,000 | -13,466,000 | 328,743,000 | 31,576,000 | 41,133,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-59,368,000
Investing CF
$-64,650,000
Financing CF
$167,084,000
CapEx
$-6,594,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.84
As of
2026-11-01
Balance + Analyst (yfinance extras)
Retained Earnings
$-439,588,000
Inventory
$22,971,000
Receivables
$23,747,000
ST Investments
$158,653,000
EBIT TTM
$-88,406,000
Pretax Income TTM
$-83,117,000
Interest Exp TTM
—
Analysts
14
Yahoo Snapshot (yfinance, live)
Total Revenue
$127,265,000
EBITDA
$-89,858,000
Free Cash Flow
$-40,097,752
Enterprise Value
$676,545,344
Total Cash
$240,204,000
Total Debt
$6,101,000
Shares Out
54,367,067
Trailing EPS
$-1.83
Book Value
$7.38
ROE
-23.9%
ROA
-15.0%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 100,251,000 | -71,681,000 | -73,200,000 | 328,743,000 | 41,133,000 | 287,610,000 | -50,925,000 |
| Dec 2024 | 65,124,000 | -45,251,000 | -54,756,000 | 149,645,000 | 395,005,000 | -245,360,000 | -48,273,000 |
| Dec 2023 | 11,995,000 | -35,850,000 | -44,099,000 | 110,040,000 | 313,145,000 | -203,105,000 | -32,445,000 |
| Dec 2022 | 179,000 | -65,844,000 | -64,751,000 | 35,527,000 | 205,561,000 | -170,034,000 | -60,208,000 |
TTM Snapshot
Revenues TTM
$119,013,000
NetIncome TTM
$-72,973,000
OpCashFlow TTM
—
Assets (Latest)
$292,387,000
Forward EPS
$-2.12
Max Pain — expiry 2027-01-15 (volume-derived — Yahoo OI feed degraded)
max pain strike: $10.00 · spot: $14.33 · call volume: 116 · put volume: 10Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| KIDS | ORTHOPEDIATRICS CORP | $820.13M | $31.41 | — |
| STVN | Stevanato Group S.p.A. | $759.94M | $15.25 | — |
| INMD | InMode Ltd. | $743.47M | $12.92 | — |
| BVS | Bioventus Inc. | $725.83M | $10.60 | — |
| AORT | ARTIVION, INC. | $891.39M | $18.27 | — |
News headlines (Yahoo Finance, 1h cache)
BBNX & SENS Launch Eversense 365 Integration With iLet Bionic Pancreas
2026-11-17 15:01 · Yahoo
Senseonics and Beta Bionics Launch Eversense® 365 and iLet® Bionic Pancreas Integration
2026-11-16 21:13 · Yahoo
Beta Bio: 3 Key Takeaways for Long-Term Investors
2026-11-09 17:20 · Yahoo
Beta Bionics Announces Participation at Upcoming Investor Conferences
2026-11-03 12:30 · Yahoo
Beta Bionics, Inc. Q3 2026 Earnings Call Summary
2026-10-28 12:30 · Yahoo
Beta Bionics (BBNX) Q3 2026 Earnings Call Transcript
2026-10-28 05:43 · Yahoo
Beta Bionics Q3 Earnings Call Highlights
2026-10-28 00:04 · Yahoo
Beta Bionics, Inc. (BBNX) Reports Q3 Loss, Beats Revenue Estimates
2026-10-27 20:15 · Yahoo
Beta Bionics Announces Third Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
2026-10-27 20:02 · Yahoo
Beta Bionics, Inc. (BBNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
2026-10-20 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.